These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26997432)

  • 1. Chaperone protein L-isoaspartate (D-aspartyl) O-methyltransferase as a novel predictor of poor prognosis in lung adenocarcinoma.
    Saito H; Yamashita M; Ogasawara M; Yamada N; Niisato M; Tomoyasu M; Deguchi H; Tanita T; Ishida K; Sugai T; Yamauchi K
    Hum Pathol; 2016 Apr; 50():1-10. PubMed ID: 26997432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock protein 90-β over-expression is associated with poor survival in stage I lung adenocarcinoma patients.
    Wu Y; Huang B; Liu Q; Liu Y
    Int J Clin Exp Pathol; 2015; 8(7):8252-9. PubMed ID: 26339394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
    Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
    Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
    He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
    Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
    Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
    Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer.
    Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
    Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer.
    Sepesi B; Cuentas EP; Canales JR; Behrens C; Correa AM; Vaporciyan A; Weissferdt A; Kalhor N; Moran C; Swisher S; Wistuba I
    Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):408-415. PubMed ID: 29195578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMPRSS4 Expression as a Marker of Recurrence in Patients with Lung Cancer.
    Chikaishi Y; Uramoto H; Koyanagi Y; Yamada S; Yano S; Tanaka F
    Anticancer Res; 2016 Jan; 36(1):121-7. PubMed ID: 26722035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma.
    Hwang JA; Song JS; Yu DY; Kim HR; Park HJ; Park YS; Kim WS; Choi CM
    Int J Clin Exp Pathol; 2015; 8(6):6627-35. PubMed ID: 26261544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.
    Guo T; Zhao S; Li Z; Li F; Li J; Gu C
    Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators.
    Rakha E; Pajares MJ; Ilie M; Pio R; Echeveste J; Hughes E; Soomro I; Long E; Idoate MA; Wagner S; Lanchbury JS; Baldwin DR; Hofman P; Montuenga LM
    Eur J Cancer; 2015 Sep; 51(14):1897-903. PubMed ID: 26235745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression levels of CYP3A4 and CYP3A5 serve as potential prognostic biomarkers in lung adenocarcinoma.
    Qixing M; Juqing X; Yajing W; Gaochao D; Wenjie X; Run S; Anpeng W; Lin X; Feng J; Jun W
    Tumour Biol; 2017 Apr; 39(4):1010428317698340. PubMed ID: 28381170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of the novel cytokine IL-38 expressed in lung adenocarcinoma: Possible association with PD-L1 expression.
    Takada K; Okamoto T; Tominaga M; Teraishi K; Akamine T; Takamori S; Katsura M; Toyokawa G; Shoji F; Okamoto M; Oda Y; Hoshino T; Maehara Y
    PLoS One; 2017; 12(7):e0181598. PubMed ID: 28727766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
    Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
    Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
    Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of adjuvant chemotherapy for lung adenocarcinoma patients with positive pleural lavage cytology findings.
    Ogawa H; Uchino K; Tanaka Y; Shimizu N; Okuda Y; Tane K; Tauchi S; Nishio W; Maniwa Y; Yoshimura M
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):34-9. PubMed ID: 25911680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
    Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
    Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral Pleural Invasion Is a Significant Prognostic Factor in Patients with Partly Solid Lung Adenocarcinoma Sized 30 mm or Smaller.
    Seok Y; Lee E
    Thorac Cardiovasc Surg; 2018 Mar; 66(2):150-155. PubMed ID: 27517168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
    Xu XY; Lin N; Li YM; Zhi C; Shen H
    Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive intraoperative pleural lavage cytology is a predictive marker of disease recurrence in stage I lung adenocarcinoma.
    Yanagawa N; Shiono S; Abiko M; Abe M; Watanabe K; Watanabe I; Uematsu M; Ogata SY; Sato T; Tamura G
    Interact Cardiovasc Thorac Surg; 2014 May; 18(5):621-5. PubMed ID: 24532312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.